l{lQBAt;8H _M1IVU B4;BRBgHNE
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
=woMtr 8Pim
VSS tqu~r
up=E9 e%s-!y
up=E9 e%s-!y
#} d]u]
#} d]u]
KY tGDGf$f
KY tGDGf$f
f_a_?f?
f_a_?f?
nw HVvV
nw HVvV
Y7 ($@ ,A[Z!# o((Q
Y7 ($@ ,A[Z!# o((Q
Y\2e\
Y\2e\
/3GRY5|RU 5%
/3GRY5|RU 5%
^LL$0A0
^LL$0A0
hv {rLL
hv {rLL
\A 4EEOE
\A 4EEOE
q2i+wyW MMd;d
q2i+wyW MMd;d
=c% u2^q^
=c% u2^q^
z6 5}iHH
z6 5}iHH
vh 9oYvr sK&
vh 9oYvr sK&
DQ x1Dz) zE2
DQ x1Dz) zE2
&a @z, Dn];5 qDltb$
&a @z, Dn];5 qDltb$
Ad &:{PW 7&\q\
Ad &:{PW 7&\q\
^Y 0j |ezPz
^Y 0j |ezPz
fD*t @R{R{
fD*t @R{R{
T8 3D++
T8 3D++
aK mO++
aK mO++
;[ B)tB)3)
;[ B)tB)3)
L$ GEC
L$ GEC
Mb fii
Mb fii
@/ J0U
@/ J0U
Y|E1 JGG
Y|E1 JGG
Hp Dn&o& 7jW_XW5hKHEWj sJ2T9\!C[J;u
Hp Dn&o& 7jW_XW5hKHEWj sJ2T9\!C[J;u
BV-uZz5uD uuu Z-Yh11
BV-uZz5uD uuu Z-Yh11
j--M}DlDYR |@j@S eohm%GG%Ie[o
j--M}DlDYR |@j@S eohm%GG%Ie[o
$z/+&zc @^@9@YD^xw /~X5kuX)25w
$z/+&zc @^@9@YD^xw /~X5kuX)25w
%xjx+ =wO|04Z4y
%xjx+ =wO|04Z4y
ZaZ k&n
ZaZ k&n
UTU|~~ )eC%lQeQ{%#C
UTU|~~ )eC%lQeQ{%#C
sgqQee ^Qy#/sQs!#$cm
sgqQee ^Qy#/sQs!#$cm
;H; j~B 0p@ mvm AJJ
;H; j~B 0p@ mvm AJJ
u2 5WWᵃ
u2 5WWᵃ
ZmZ H%
ZmZ H%
LtL ovv
LtL ovv
aka $!L
aka $!L
!` DIIRJIIG
!` DIIRJIIG
Z$Z LL AUvw w@xx|x6K
Z$Z LL AUvw w@xx|x6K
()bt)E-
()bt)E-
dJJ,DJJ
dJJ,DJJ
b%
b%
XgX [[
XgX [[
:s: 1pQ
:s: 1pQ
~@ Vk3
~@ Vk3
3Q3 ef8vf DFmr pF7k8
3Q3 ef8vf DFmr pF7k8
Yq?r6uQj8Z ~1`[~`o gqUn88 Z7y#)e7e`#!2
Yq?r6uQj8Z ~1`[~`o gqUn88 Z7y#)e7e`#!2
qHax2
Mdd N-0`K`
z
z
\
\
T
T
QQ$eQjUc
mA5-A5- @G[Z k, jzKz[hj)
qHax2
/YLL2FF 3?l1 !|VZ
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
^o!{omo|oU⁶ CdWW0 # /A] =oowX
#} d]u]
\
:fJE\[MEbfI
#} d]u]
KY tGDGf$f
\
:fJE\[MEbfI
KY tGDGf$f
f_a_?f?
\
:fJE\[MEbfI
f_a_?f?
nw HVvV
T
:fJE\[MEbfI
nw HVvV
}gPAFg:A0 iw~Aw +qp 6)V6[6iIAz
Y7 ($@ ,A[Z!# o((Q
\
:fJE\[MEbfI
Y7 ($@ ,A[Z!# o((Q
}-3b/}`-K}7⁷ &J&_gpJ t V$8 KCQKR
Y\2e\
z
:fJE\[MEbfI
Y\2e\
P#PtGh?= VZ2!O? o|*)|pxt
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
cKcqcVbbn %y`6w 9 V*1-z n*tSF
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
3p3?3wDnn ytQ$5 f ,OUxx ovf:_
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
c_uA/]cz 0)MLR k 1!$ mkU-@
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
B7KM;irN EO9O^z? 2#uX
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
X&XFQAJATF aOpv0u]c 3`t3$3En@#
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
#$#cyjmBB Ajjnp Vb8F
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
PpP-zcZLz &@zhζ 6wQ6b6p31\
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
lvl:HMbKM VS(`x #;#F+;+%
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
[{[fQ#pbp `?Gr/ t]Pt\t75N1
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
qqq+uyyy AJ@ox 1t?q
/3GRY5|RU 5%
T
:fJE\[MEbfI
/3GRY5|RU 5%
2t2HAqk# 6,7H9 u%8K
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
Q7Qk!!Y⁴ 2AV,x 2}=5
^LL$0A0
T
:fJE\[MEbfI
^LL$0A0
hv {rLL
T
:fJE\[MEbfI
hv {rLL
}6zNoYY:ᵇ r$f {02+eBqpe0BkD
\A 4EEOE
T
:fJE\[MEbfI
\A 4EEOE
q2i+wyW MMd;d
T
:fJE\[MEbfI
q2i+wyW MMd;d
=c% u2^q^
T
:fJE\[MEbfI
=c% u2^q^
z6 5}iHH
T
:fJE\[MEbfI
z6 5}iHH
Cdk1SdXd:d3⁵ -W-o: Q&zs?
vh 9oYvr sK&
T
:fJE\[MEbfI
vh 9oYvr sK&
DQ x1Dz) zE2
\
:fJE\[MEbfI
DQ x1Dz) zE2
u6uBbX`lX $`d8L FHoF]Fn5Q8
up=E9 e%s-!y
z
:fJE\[MEbfI
up=E9 e%s-!y
p6aeEoU?³ R-`Ku Oc\?
&a @z, Dn];5 qDltb$
z
:fJE\[MEbfI
&a @z, Dn];5 qDltb$
373EW44aB ,=l!T )Z-)+)iOuX
&a @z, Dn];5 qDltb$
z
:fJE\[MEbfI
&a @z, Dn];5 qDltb$
m{p;T^;f² 1+S\0 S19S=S0lgF
&a @z, Dn];5 qDltb$
z
:fJE\[MEbfI
&a @z, Dn];5 qDltb$
FtZn7ntSeh&v Hp|zS ]gC]
Ad &:{PW 7&\q\
\
:fJE\[MEbfI
Ad &:{PW 7&\q\
^Y 0j |ezPz
\
:fJE\[MEbfI
^Y 0j |ezPz
fD*t @R{R{
\
:fJE\[MEbfI
fD*t @R{R{
q2i+wyW MMd;d
\
:fJE\[MEbfI
q2i+wyW MMd;d
KY tGDGf$f
\
:fJE\[MEbfI
KY tGDGf$f
hv {rLL
\
:fJE\[MEbfI
hv {rLL
T8 3D++
\
:fJE\[MEbfI
T8 3D++
aK mO++
\
:fJE\[MEbfI
aK mO++
;[ B)tB)3)
\
:fJE\[MEbfI
;[ B)tB)3)
L$ GEC
\
:fJE\[MEbfI
L$ GEC
Mb fii
\
:fJE\[MEbfI
Mb fii
@/ J0U
\
:fJE\[MEbfI
@/ J0U
Y|E1 JGG
T
:fJE\[MEbfI
Y|E1 JGG
Hp Dn&o& 7jW_XW5hKHEWj sJ2T9\!C[J;u
z
:fJE\[MEbfI
Hp Dn&o& 7jW_XW5hKHEWj sJ2T9\!C[J;u
#J(nuU56U6u5¹ |/;N { ?siW 6G8(p
BV-uZz5uD uuu Z-Yh11
T
:fJE\[MEbfI
BV-uZz5uD uuu Z-Yh11
4t4#xYarY TWQ!_D gSMg1
j--M}DlDYR |@j@S eohm%GG%Ie[o
z
:fJE\[MEbfI
j--M}DlDYR |@j@S eohm%GG%Ie[o
dCKF})FqkKk} 1LC, Op,OHOCcO5
$z/+&zc @^@9@YD^xw /~X5kuX)25w
\
:fJE\[MEbfI
$z/+&zc @^@9@YD^xw /~X5kuX)25w
%xjx+ =wO|04Z4y
T
:fJE\[MEbfI
%xjx+ =wO|04Z4y
FtZn7ntSeh&v Hp|zS ]gC]
ZaZ k&n
\
:fJE\[MEbfI
ZaZ k&n
cjc)Vp77h LTLUe bYx j45@ {XT{c{#J:v
UTU|~~ )eC%lQeQ{%#C
z
:fJE\[MEbfI
UTU|~~ )eC%lQeQ{%#C
z)zHO++TJ Y_3? (2e()
UTU|~~ )eC%lQeQ{%#C
z
:fJE\[MEbfI
UTU|~~ )eC%lQeQ{%#C
sgqQee ^Qy#/sQs!#$cm
z
:fJE\[MEbfI
sgqQee ^Qy#/sQs!#$cm
;H; j~B 0p@ mvm AJJ
T
:fJE\[MEbfI
;H; j~B 0p@ mvm AJJ
p5x]5G5h+tB 7Q3~S FV1FAF*5x^
u2 5WWᵃ
\
:fJE\[MEbfI
u2 5WWᵃ
ZmZ H%
T
:fJE\[MEbfI
ZmZ H%
LtL ovv
T
:fJE\[MEbfI
LtL ovv
aka $!L
T
:fJE\[MEbfI
aka $!L
!` DIIRJIIG
T
:fJE\[MEbfI
!` DIIRJIIG
Z$Z LL AUvw w@xx|x6K
z
:fJE\[MEbfI
Z$Z LL AUvw w@xx|x6K
()bt)E-
z
:fJE\[MEbfI
()bt)E-
UTU|~~ )eC%lQeQ{%#C
z
:fJE\[MEbfI
UTU|~~ )eC%lQeQ{%#C
dCKF})FqkKk} 1LC, Op,OHOCcO5
dJJ,DJJ
\
:fJE\[MEbfI
dJJ,DJJ
b%
\
:fJE\[MEbfI
b%
XgX [[
\
:fJE\[MEbfI
XgX [[
:s: 1pQ
\
:fJE\[MEbfI
:s: 1pQ
~@ Vk3
\
:fJE\[MEbfI
~@ Vk3
aka $!L
T
:fJE\[MEbfI
aka $!L
3Q3 ef8vf DFmr pF7k8
T
:fJE\[MEbfI
3Q3 ef8vf DFmr pF7k8
Yq?r6uQj8Z ~1`[~`o gqUn88 Z7y#)e7e`#!2
T
:fJE\[MEbfI
Yq?r6uQj8Z ~1`[~`o gqUn88 Z7y#)e7e`#!2
zAmgen collaboration; BeiGene has China commercial rights. TEnsem collaboration; BeiGene has global rights. \DualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. MLeads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. |Zymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. HAmgen collaboration; BeiGene has development and commercialization rights in China. ?In combination with Zanubrutinib. *May include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.